PMC:7600245 / 1112-1531
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 296-304 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T2 | 411-414 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T7 | 363-378 | Disease | denotes | viral infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
| T8 | 369-378 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T4 | 190-199 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
| T5 | 201-213 | Chemical | denotes | polypeptides | http://purl.obolibrary.org/obo/CHEBI_15841 |
| T6 | 296-304 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 363-378 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infection |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T11 | 80-149 | Sentence | denotes | Their anti-inflammatory/immune-modulatory effects are also described. |
| T12 | 150-241 | Sentence | denotes | The reviewed therapeutics include small molecules, polypeptides, and monoclonal antibodies. |
| T13 | 242-379 | Sentence | denotes | At the molecular level, the therapeutics target viral proteins or processes that facilitate the post-entry stages of the viral infection. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 26 | 363-378 | Disease | denotes | viral infection | MESH:D001102 |